Click for best price
Orphan Drugs Market Size, Share 2022
An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because they are so rare, would not be profitable to produce without government assistance. The conditions are referred to as orphan diseases.
This report contains market size and forecasts of Orphan Drugs in Global, including the following market information:
Global Orphan Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Orphan Drugs market was valued at 143200 million in 2021 and is projected to reach US$ 269190 million by 2028, at a CAGR of 9.4% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Orphan Drugs include Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Orphan Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Orphan Drugs Market Segment Percentages, by Type, 2021 (%)
Oncology
Pulmonary
Neurology
Hematology
Endocrinology
Cardio-vascular
Metabolic Disorders
Others
Global Orphan Drugs Market, by End Users, 2017-2022, 2023-2028 ($ millions)
Global Orphan Drugs Market Segment Percentages, by End Users, 2021 (%)
Baby and Child
Teenager
Adult
Other
Global Orphan Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Orphan Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Orphan Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly
| Report Attributes |
Report Details |
| Report Title |
Orphan Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
63 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Orphan Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End Users
1.3 Global Orphan Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs Overall Market Size
2.1 Global Orphan Drugs Market Size: 2021 VS 2028
2.2 Global Orphan Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orphan Drugs Players in Global Market
3.2 Top Global Orphan Drugs Companies Ranked by Revenue
3.3 Global Orphan Drugs Revenue by Companies
3.4 Top 3 and Top 5 Orphan Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Orphan Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orphan Drugs Players in Global Market
3.6.1 List of Global Tier 1 Orphan Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Orphan Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Orphan Drugs Market Size Markets, 2021 & 2028
4.1.2 Oncology
4.1.3 Pulmonary
4.1.4 Neurology
4.1.5 Hematology
4.1.6 Endocrinology
4.1.7 Cardio-vascular
4.1.8 Metabolic Disorders
4.1.9 Others
4.2 By Type - Global Orphan Drugs Revenue & Forecasts
4.2.1 By Type - Global Orphan Drugs Revenue, 2017-2022
4.2.2 By Type - Global Orphan Drugs Revenue, 2023-2028
4.2.3 By Type - Global Orphan Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orphan Drugs Market Size, 2021 & 2028
5.1.2 Baby and Child
5.1.3 Teenager
5.1.4 Adult
5.1.5 Other
5.2 By End Users - Global Orphan Drugs Revenue & Forecasts
5.2.1 By End Users - Global Orphan Drugs Revenue, 2017-2022
5.2.2 By End Users - Global Orphan Drugs Revenue, 2023-2028
5.2.3 By End Users - Global Orphan Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Orphan Drugs Market Size, 2021 & 2028
6.2 By Region - Global Orphan Drugs Revenue & Forecasts
6.2.1 By Region - Global Orphan Drugs Revenue, 2017-2022
6.2.2 By Region - Global Orphan Drugs Revenue, 2023-2028
6.2.3 By Region - Global Orphan Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Orphan Drugs Revenue, 2017-2028
6.3.2 US Orphan Drugs Market Size, 2017-2028
6.3.3 Canada Orphan Drugs Market Size, 2017-2028
6.3.4 Mexico Orphan Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Orphan Drugs Revenue, 2017-2028
6.4.2 Germany Orphan Drugs Market Size, 2017-2028
6.4.3 France Orphan Drugs Market Size, 2017-2028
6.4.4 U.K. Orphan Drugs Market Size, 2017-2028
6.4.5 Italy Orphan Drugs Market Size, 2017-2028
6.4.6 Russia Orphan Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Orphan Drugs Market Size, 2017-2028
6.4.8 Benelux Orphan Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Orphan Drugs Revenue, 2017-2028
6.5.2 China Orphan Drugs Market Size, 2017-2028
6.5.3 Japan Orphan Drugs Market Size, 2017-2028
6.5.4 South Korea Orphan Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Orphan Drugs Market Size, 2017-2028
6.5.6 India Orphan Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Orphan Drugs Revenue, 2017-2028
6.6.2 Brazil Orphan Drugs Market Size, 2017-2028
6.6.3 Argentina Orphan Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Orphan Drugs Revenue, 2017-2028
6.7.2 Turkey Orphan Drugs Market Size, 2017-2028
6.7.3 Israel Orphan Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Orphan Drugs Market Size, 2017-2028
6.7.5 UAE Orphan Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporate Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Orphan Drugs Major Product Offerings
7.1.4 Bristol-Myers Squibb Orphan Drugs Revenue in Global Market (2017-2022)
7.1.5 Bristol-Myers Squibb Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Orphan Drugs Major Product Offerings
7.2.4 Roche Orphan Drugs Revenue in Global Market (2017-2022)
7.2.5 Roche Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Orphan Drugs Major Product Offerings
7.3.4 Novartis Orphan Drugs Revenue in Global Market (2017-2022)
7.3.5 Novartis Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Orphan Drugs Major Product Offerings
7.4.4 Johnson & Johnson Orphan Drugs Revenue in Global Market (2017-2022)
7.4.5 Johnson & Johnson Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Orphan Drugs Major Product Offerings
7.5.4 Pfizer Orphan Drugs Revenue in Global Market (2017-2022)
7.5.5 Pfizer Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Orphan Drugs Major Product Offerings
7.6.4 Amgen Orphan Drugs Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Orphan Drugs Major Product Offerings
7.7.4 Sanofi Orphan Drugs Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 AstraZeneca
7.8.1 AstraZeneca Corporate Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Orphan Drugs Major Product Offerings
7.8.4 AstraZeneca Orphan Drugs Revenue in Global Market (2017-2022)
7.8.5 AstraZeneca Key News
7.9 Takeda
7.9.1 Takeda Corporate Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Orphan Drugs Major Product Offerings
7.9.4 Takeda Orphan Drugs Revenue in Global Market (2017-2022)
7.9.5 Takeda Key News
7.10 Vertex Pharmaceuticals
7.10.1 Vertex Pharmaceuticals Corporate Summary
7.10.2 Vertex Pharmaceuticals Business Overview
7.10.3 Vertex Pharmaceuticals Orphan Drugs Major Product Offerings
7.10.4 Vertex Pharmaceuticals Orphan Drugs Revenue in Global Market (2017-2022)
7.10.5 Vertex Pharmaceuticals Key News
7.11 AbbVie
7.11.1 AbbVie Corporate Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Orphan Drugs Major Product Offerings
7.11.4 AbbVie Orphan Drugs Revenue in Global Market (2017-2022)
7.11.5 AbbVie Key News
7.12 Biogen
7.12.1 Biogen Corporate Summary
7.12.2 Biogen Business Overview
7.12.3 Biogen Orphan Drugs Major Product Offerings
7.12.4 Biogen Orphan Drugs Revenue in Global Market (2017-2022)
7.12.5 Biogen Key News
7.13 Eli Lilly
7.13.1 Eli Lilly Corporate Summary
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Orphan Drugs Major Product Offerings
7.13.4 Eli Lilly Orphan Drugs Revenue in Global Market (2017-2022)
7.13.5 Eli Lilly Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Orphan Drugs Market Opportunities & Trends in Global Market
Table 2. Orphan Drugs Market Drivers in Global Market
Table 3. Orphan Drugs Market Restraints in Global Market
Table 4. Key Players of Orphan Drugs in Global Market
Table 5. Top Orphan Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Orphan Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Orphan Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Orphan Drugs Product Type
Table 9. List of Global Tier 1 Orphan Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orphan Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Orphan Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Orphan Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By End Users ? Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By End Users - Orphan Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By End Users - Orphan Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Orphan Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Orphan Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Orphan Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Orphan Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Bristol-Myers Squibb Corporate Summary
Table 31. Bristol-Myers Squibb Orphan Drugs Product Offerings
Table 32. Bristol-Myers Squibb Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Orphan Drugs Product Offerings
Table 35. Roche Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Orphan Drugs Product Offerings
Table 38. Novartis Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Orphan Drugs Product Offerings
Table 41. Johnson & Johnson Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Orphan Drugs Product Offerings
Table 44. Pfizer Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Orphan Drugs Product Offerings
Table 47. Amgen Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Orphan Drugs Product Offerings
Table 50. Sanofi Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Orphan Drugs Product Offerings
Table 53. AstraZeneca Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Takeda Corporate Summary
Table 55. Takeda Orphan Drugs Product Offerings
Table 56. Takeda Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Vertex Pharmaceuticals Corporate Summary
Table 58. Vertex Pharmaceuticals Orphan Drugs Product Offerings
Table 59. Vertex Pharmaceuticals Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 60. AbbVie Corporate Summary
Table 61. AbbVie Orphan Drugs Product Offerings
Table 62. AbbVie Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Biogen Corporate Summary
Table 64. Biogen Orphan Drugs Product Offerings
Table 65. Biogen Orphan Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Eli Lilly Corporate Summary
Table 67. Eli Lilly Orphan Drugs Product Offerings
Table 68. Eli Lilly Orphan Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Orphan Drugs Segment by Type in 2021
Figure 2. Orphan Drugs Segment by End Users in 2021
Figure 3. Global Orphan Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Orphan Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Orphan Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orphan Drugs Revenue in 2021
Figure 8. By Type - Global Orphan Drugs Revenue Market Share, 2017-2028
Figure 9. By End Users - Global Orphan Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Orphan Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Orphan Drugs Revenue Market Share, 2017-2028
Figure 12. US Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Orphan Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Orphan Drugs Revenue Market Share, 2017-2028
Figure 24. China Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Orphan Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Orphan Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Orphan Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Bristol-Myers Squibb Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Takeda Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Vertex Pharmaceuticals Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AbbVie Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Biogen Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Eli Lilly Orphan Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
